Clinical Perspectives on Cannabis Use Disorder: Diagnosis, Treatment, and Mental Health Implications
Cannabis use disorder (CUD) is a topic of growing importance in the realm of mental health care. In a world where the perception of cannabis is rapidly shifting, it is crucial for mental health professionals to stay informed about the latest research, understand the nature of CUD, and recognize the unique challenges associated with CUD.
What is Cannabis Use Disorder (CUD)
CUD is a medical diagnosis defined as a problematic pattern of cannabis use that results in significant impairment or distress in an individual. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for CUD includes a range of symptoms from a persistent desire to use cannabis to disruptions in fulfilling obligations at work, school, or home. Additionally, it incorporates the presence of withdrawal symptoms and tolerance, which are key indicators of most substance use disorders. As such, CUD represents a serious health concern, requiring careful diagnosis and management in the field of mental health. The prevalence of CUD varies globally, with some regions experiencing higher rates due to factors like legal status and cultural attitudes toward cannabis use. Demographically, CUD is more commonly diagnosed in younger age groups, particularly among adolescents and young adults, and tends to be more prevalent in males compared to females. Recent statistics indicate an increase in CUD cases, correlating with the rising accessibility and legalization of cannabis in various countries. The impact of CUD extends beyond individual health, affecting educational, occupational, and social functioning, and is often associated with co-occurring mental health disorders. Addressing CUD effectively necessitates a comprehensive understanding of its prevalence, demographic distribution, and multi-faceted impact on individuals and society.
Understanding Cannabis (Marijuana)
Cannabis, widely known as marijuana, comes in various forms and is used in numerous ways. A green-gray mixture of the dried flowers of Cannabis Sativa L plant, commonly referred to by a plethora of slang terms such as “buds” or “herb”. Among stronger forms of marijuana are sinsemilla, derived from specially tended female plants, and concentrated resins including oils, edibles, tinctures, lotions, and balms. The primary psychoactive component in marijuana is delta-9-tetrahydrocannabinol (THC), which is responsible for most of the intoxicating effects sought by users. The cannabis plant contains over 500 other chemicals, including more than 100 compounds that are chemically related to THC, known as cannabinoids. Cannabidiol (CBD) is non-psychoactive and is often highlighted for its potential therapeutic benefits without inducing a high.
Symptoms of Cannabis Use Disorder
CUD is a condition characterized by the problematic use of cannabis and is diagnosed based on certain criteria, physical and psychological symptoms, and behavioral changes.
Criteria For Diagnosis (DSM-5-TR Guidelines)
According to the DSM-5-TR, a diagnosis of CUD requires the presence of at least two of the following symptoms within a 12-month period:
- Cannabis is often taken in larger amounts or over a longer period than was intended.
- There is a desire to quit or have unsuccessful efforts to cut down or control cannabis use.
- Craving, or a strong desire or urge to use cannabis.
- A great deal of time is spent in activities necessary to obtain, use, or recover from cannabis effects.
- Recurrent cannabis use leads to failing to fulfill major role obligations at work, school, or home.
- Continued cannabis use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of cannabis.
- Important social, occupational, or recreational activities are given up or reduced because of cannabis use.
- Recurrent cannabis use in situations in which it is physically hazardous.
- Cannabis use is continued despite knowledge of having persistent or recurrent physical or psychological problems that are likely to have been caused by cannabis.
- Tolerance, as defined by a need for increased amounts of cannabis to achieve intoxication, or a markedly diminished effect with continued use of the same amount of cannabis.
- Withdrawal symptoms are experienced when not using cannabis or when cannabis is taken to relieve or avoid withdrawal symptoms.
Physical Symptoms
Physical symptoms of CUD include respiratory issues from smoking, increased heart rate, dry mouth, red eyes, increased appetite, and coordination problems. Long-term use can lead to chronic cough, bronchitis, and increased risk of respiratory infections.
Psychological Symptoms
Psychological symptoms include impaired memory, altered judgment, language impairment, and delayed decision-making. Users might also experience temporary hallucinations and paranoia, especially with high doses. In the long term, there can be cognitive impairments and, in some cases, exacerbation of underlying mental health disorders like anxiety and depression.
Behavioral Symptoms
Behavioral symptoms include increased use over time, spending a significant amount of time obtaining and using cannabis, and persistent use despite the negative consequences. There can also be a reduction in social, occupational, or recreational activities and continued use in physically hazardous situations.
Causes and Risk Factors
CUD can be attributed to a complex interplay of various causes and risk factors. Genetic predisposition plays a significant role in the development of CUD. Studies suggest that genetics can influence an individual’s susceptibility to substance use disorders, including CUD, though the exact genetic factors are still being researched. Environmental factors also contribute significantly; individuals who grow up in environments where cannabis use is normalized or who have easy access to cannabis are at a higher risk. Social and psychological factors are equally influential in the onset of CUD. Peer pressure, especially during adolescence, and the use of cannabis as a coping mechanism for stress or emotional distress can escalate the risk of developing the disorder. Additionally, co-occurring mental health disorders such as anxiety, depression, and bipolar disorder are commonly observed in individuals with CUD. These mental health conditions can both contribute to and exacerbate the severity of cannabis use disorder. Understanding the multifaceted nature of these risk factors is crucial for effective prevention and treatment strategies.
Diagnosis
The diagnosis of CUD is primarily based on criteria outlined in the DSM-5-TR. The process of diagnosing CUD typically involves the following steps:
- Clinical Assessment: A comprehensive clinical evaluation is conducted by a mental health provider. This includes a detailed interview about the individual’s cannabis use, lifestyle, mental health history, and any associated symptoms or problems.
- DSM-5-TR Criteria: The DSM-5-TR outlines specific criteria for the diagnosis of CUD. An individual must exhibit at least two of the above symptoms within a 12-month period.
- Severity Assessment: The severity of CUD is determined based on the number of criteria met:
- Mild: 2-3 symptoms.
- Moderate: 4-5 symptoms.
- Severe: 6 or more symptoms.
- Rule Out Other Conditions: CUD should be differentiated from other conditions, especially when symptoms overlap with other substance use disorders or mental health issues.
- Evaluation of Impact: The diagnosis also involves evaluating the impact of cannabis use on the individual’s life, including social, occupational, and personal areas.
A diagnosis of CUD is made after careful consideration of these factors, ensuring that the pattern of cannabis use is problematic and leads to significant impairment or distress. Treatment plans are then tailored based on the individual’s specific needs and the severity of the disorder.
Treatment Approaches
The treatment of CUD involves a multifaceted approach tailored to the individual’s specific needs and circumstances. Comprehensive treatment approaches are further discussed below.
Overview of Treatment Options
Treatment for CUD typically encompasses a combination of behavioral therapies, medication (if applicable), and support mechanisms. The primary goal is to help the individual reduce or stop cannabis use and address related psychological and social issues.
Behavioral Therapies are often the primary treatments for CUD.
- Cognitive Behavioral Therapy helps individuals identify and change negative thinking and behavior patterns. It equips them with strategies to cope with cravings and avoid situations that might lead to cannabis use.
- Motivational Enhancement Therapy (MET) is designed to produce rapid, internally motivated change. This therapy does not attempt to treat the individual but rather mobilizes their internal resources for change and engagement in treatment.
Medication-Assisted Treatment: Currently, there are no Food and Drug Administration (FDA)-approved medications specifically for the treatment of CUD. However, medications may be used to manage withdrawal symptoms or co-occurring mental health disorders like anxiety or depression. Tetrahydrocannabinol, gabapentin, and N-acetylcysteine have shown potential as treatment options however, more research is needed to determine adequate dosages and efficacy.
Importance of a Personalized Treatment Plan:
Each individual’s journey with CUD is unique, necessitating a personalized treatment plan. Factors such as the severity of the disorder, co-occurring mental health conditions, and personal circumstances must be considered in developing an effective treatment strategy.
Role of Support Groups and Family Therapy:
Support groups can provide a sense of community and mutual understanding, which is invaluable in recovery. Family therapy is also important, as it addresses the impact of CUD on family dynamics and helps family members develop supportive strategies.
The treatment of CUD is a comprehensive process that requires a combination of behavioral therapy, potential medication management, personalized care plans, and support from groups and families. The approach should be flexible, evidence-based, and responsive to the needs of the individual.
Challenges in Treatment
Treating CUD presents a range of challenges that can significantly impact the effectiveness of recovery efforts. Barriers to seeking treatment include the stigma surrounding cannabis use and mental health, lack of awareness or denial about the severity of one’s condition, difficulties in accessing treatment services, and legal concerns in regions where cannabis use is illegal. Another critical aspect of treatment is relapse prevention and management, which involves identifying and managing triggers, ensuring ongoing support and follow-up, and teaching coping strategies to handle stress, cravings, and social pressures. Additionally, addressing co-occurring disorders is a complex but essential part of the treatment process. Many individuals with CUD also suffer from other mental health issues such as anxiety or depression, necessitating an integrated treatment approach that simultaneously addresses both CUD and any accompanying mental health disorders. This approach should be tailored to each individual’s needs, with regular monitoring and adjustments to the treatment plan.
Prevention
Preventing CUD necessitates a comprehensive strategy encompassing education, community involvement, and policy measures. Early education and awareness are fundamental, with schools implementing age-appropriate, evidence-based drug education programs and public health campaigns providing accurate information about cannabis’s potential harms. Community-based interventions are also vital. These include youth engagement programs that offer alternative activities and support, as well as community health centers providing resources and counseling services. Engaging parents and families in these educational efforts is crucial for fostering effective dialogues about substance use. On the policy front, effective regulatory measures are key in controlling cannabis availability and accessibility, particularly to minors. This includes strict regulations on the sale and distribution of cannabis, enforcing age restrictions, monitoring product potency, and reducing the marketing and advertising of cannabis products. A collective effort across educational systems, healthcare services, community organizations, and government bodies is essential in creating a holistic environment that minimizes the risk of CUD and promotes healthy choices.
Moving Forward
The importance of continued research and education in this field cannot be overstated. As cannabis use becomes more widespread and socially accepted, understanding the nuances of CUD is crucial for healthcare professionals. Ongoing research is essential to uncover new treatment modalities, understand the long-term effects of cannabis use, and refine diagnostic criteria. Education plays a pivotal role in raising awareness, reducing stigma, and informing effective prevention strategies.
For individuals and families dealing with CUD, accessing the right resources and support is critical. This includes specialized treatment programs, support groups, and educational materials. Families play a key role in the recovery process, and resources that offer guidance and support for families are invaluable. Healthcare providers should also be aware of these resources to make appropriate referrals and provide comprehensive care.
Addressing Cannabis Use Disorder CUD effectively requires a collaborative, informed, and empathetic approach that considers the unique needs of each individual. Through continued research, education, and the provision of supportive resources, this complex disorder can be better understood, treated, and prevented.
Elissa Singson, MSN, APRN, PHN, CPNP-AC is an infectious disease pediatric nurse practitioner, health writer, and mother of two. She writes content to empower healthcare professionals, patients, and families with health and medical knowledge. She also loves to share tips on work productivity and efficiency to prevent healthcare provider burnout.
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders: DSM-5-TR (5th ed.). American Psychiatric Association Publishing. https://www.appi.org/products/dsm
CDC. (2024, April 30). Cannabis Facts and Stats. Cannabis and Public Health. https://www.cdc.gov/cannabis/data-research/facts-stats/?CDC_AAref_Val=https://www.cdc.gov/marijuana/data-statistics.htm
Loflin, M. J. E., Kiluk, B. D., Huestis, M. A., Aklin, W. M., Budney, A. J., Carroll, K. M., D’Souza, D. C., Dworkin, R. H., Gray, K. M., Hasin, D. S., Lee, D. C., Le Foll, B., Levin, F. R., Lile, J. A., Mason, B. J., McRae-Clark, A. L., Montoya, I., Peters, E. N., Ramey, T., & Turk, D. C. (2020). The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and Alcohol Dependence, 212(212), 1–9. https://doi.org/10.1016/j.drugalcdep.2020.107993
National Institute on Drug Abuse. (2024, September 24). Cannabis | National Institute on Drug Abuse. National Institute on Drug Abuse. https://nida.nih.gov/research-topics/cannabis#what-is-cannabis
Patel, J., & Marwaha, R. (2019). Cannabis use disorder. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538131/
Explore Our Latest Posts
Stay up to date with expert insights, industry news, and practical tips through our regularly updated blog.